Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000121

Chief Executive Officer sold 75,000 shares at $25.46 ($1,909,665)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Congleton Jon Chief Executive Officer 2026-09-30 Sale 10b5-1 −75,000 $25.46 $1,909,665 528,621 D
Open-market sales · 75,000 sh · avg $25.46 · $1,909,665
Loading xslF345X06/wk-form4_1790978009.xml…